Jing Li

Title: Innovations and Contributions of Inventor Jing Li

Introduction

Jing Li is an accomplished inventor based in Lynnfield, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of protein characterization. With a total of 3 patents, her work has advanced our understanding of various human proteins and their applications.

Latest Patents

One of Jing Li's latest patents is focused on the cloning and characterization of a CD2 binding protein (CD2BP2). This patent describes a human CD2 cytoplasmic tail binding protein, CD2BP2, along with the nucleic acids encoding the protein. The patent also details expression vectors and recombinant host cells that comprise nucleic acids encoding the CD2BP2 protein, as well as methods of use for the CD2BP2 protein and its encoding nucleic acids. Another significant patent involves the cloning and characterization of a CDC 15-like adaptor protein (CD2BP1). This patent similarly describes a human CD2 cytoplasmic tail binding protein, CD2BP1, and includes the nucleic acids encoding the protein, expression vectors, recombinant host cells, and methods of use for the CD2BP1 protein and its encoding nucleic acids.

Career Highlights

Throughout her career, Jing Li has worked with prestigious institutions such as Dana-Farber Cancer Institute Inc. and Harvard College. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Ellis L. Reinherz and Kazuhisa Nishizawa. Their collaborative efforts have further enhanced the impact of her research and innovations.

Conclusion

Jing Li's contributions to the field of biotechnology through her patents and collaborations highlight her role as a significant inventor. Her work continues to influence the understanding of human proteins and their potential applications in medicine.